Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Blood Adv. 2020 Jun 9;4(11):2387-2391. doi: 10.1182/bloodadvances.2019000664.

Abstract

  1. Therapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppression Therapy
  • Interleukin-15* / antagonists & inhibitors
  • JC Virus*
  • Leukoencephalopathy, Progressive Multifocal* / etiology
  • Leukoencephalopathy, Progressive Multifocal* / therapy
  • Male
  • United States

Substances

  • Interleukin-15